Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kessler

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Blood|June 15, 1997
The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidityC M Kessler, Z Tang, H M Jacobs, et al.
American Journal of Hematology|October 1, 1995
Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulationP Chang, D L Aronson, D G Borenstein, et al.
Journal of Clinical Neuro-Ophthalmology|September 1, 1993
Carotid artery disease in vascular ocular syndromesM Müller, K Wessel, E Mehdorn, et al.
Thrombosis Research|January 1, 1990
Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagenC M Kessler, C M Floyd, S C Frantz, et al.
American Journal of Hematology|March 12, 1998
Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phaseD M Weinstock, P Chang, D L Aronson, et al.
Psychopharmacology Communications|January 1, 1975
Assessment of antipsychotic activity of an unique agent: SU-23397E H Mielke, D M Gallant, G Bishop, et al.
The American Journal of the Medical Sciences|June 1, 1986
Treatment of silastic catheter-induced central vein septic thrombophlebitisM S Topiel, R T Bryan, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2009
von Willebrand disease in the 21st century: current approaches and new challengesP M Mannucci, A B Federici, A H James, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 28, 2016
Efficacy and safety of a VWF/FVIII concentrate (wilate<sup>®</sup> ) in inherited von Willebrand disease patients undergoing surgical proceduresA Srivastava, M Serban, S Werner, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Blood|June 15, 1997
The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidityC M Kessler, Z Tang, H M Jacobs, et al.
American Journal of Hematology|October 1, 1995
Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulationP Chang, D L Aronson, D G Borenstein, et al.
Journal of Clinical Neuro-Ophthalmology|September 1, 1993
Carotid artery disease in vascular ocular syndromesM Müller, K Wessel, E Mehdorn, et al.
Thrombosis Research|January 1, 1990
Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagenC M Kessler, C M Floyd, S C Frantz, et al.
American Journal of Hematology|March 12, 1998
Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phaseD M Weinstock, P Chang, D L Aronson, et al.
Psychopharmacology Communications|January 1, 1975
Assessment of antipsychotic activity of an unique agent: SU-23397E H Mielke, D M Gallant, G Bishop, et al.
The American Journal of the Medical Sciences|June 1, 1986
Treatment of silastic catheter-induced central vein septic thrombophlebitisM S Topiel, R T Bryan, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2009
von Willebrand disease in the 21st century: current approaches and new challengesP M Mannucci, A B Federici, A H James, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 28, 2016
Efficacy and safety of a VWF/FVIII concentrate (wilate<sup>®</sup> ) in inherited von Willebrand disease patients undergoing surgical proceduresA Srivastava, M Serban, S Werner, et al.
Pageof 15